Keenova Therapeutics plc Payments for Restructuring
Keenova Therapeutics plc reported Payments for Restructuring of $9.30 million for the 13-month period ending 2024-12-27, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-04-15
- Keenova Therapeutics plc payments for restructuring for the quarter ending 2020-09-25 was $16.20M, a 121.92% increase year-over-year.
- Keenova Therapeutics plc payments for restructuring for the quarter ending 2020-06-26 was $800.00K, a 74.19% decline year-over-year.
- Keenova Therapeutics plc payments for restructuring for the quarter ending 2020-03-27 was $33.20M, a 210.28% increase year-over-year.
- Keenova Therapeutics plc payments for restructuring for the quarter ending 2019-09-27 was $7.30M, a 2.67% decline year-over-year.
- Keenova Therapeutics plc payments for restructuring for fiscal 2011 was $3.50M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 10 month | Payments for Restructuring 12 month | Payments for Restructuring 13 month |
|---|---|---|---|---|---|---|
| 2024-12-27 | $9.30M 10-K · filed 2026-04-15 | |||||
| 2023-11-14 | $5.40M 10-K · filed 2026-04-15 | |||||
| 2020-09-25 | $16.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $17.00M derived: sum of 2 quarters · filed 2020-11-03 | $50.20M 10-Q · filed 2020-11-03 | |||
| 2020-06-26 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $34.00M 10-Q · filed 2020-08-04 | ||||
| 2020-03-27 | $33.20M 10-Q · filed 2020-05-06 | |||||
| 2019-09-27 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $10.40M derived: sum of 2 quarters · filed 2019-11-05 | $21.10M 10-Q · filed 2019-11-05 | |||
| 2019-06-28 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $13.80M 10-Q · filed 2019-08-06 | ||||
| 2019-03-29 | $10.70M 10-Q · filed 2019-05-07 | |||||
| 2018-09-28 | $7.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $18.60M derived: sum of 2 quarters · filed 2018-11-06 | $33.40M 10-Q · filed 2018-11-06 | |||
| 2018-06-29 | $11.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $25.90M 10-Q · filed 2018-08-07 | ||||
| 2018-03-30 | $14.80M 10-Q · filed 2018-05-08 | |||||
| 2017-09-29 | $5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $13.20M derived: sum of 2 quarters · filed 2017-11-07 | $23.70M 10-Q · filed 2017-11-07 | $31.20M derived: sum of 4 quarters · filed 2017-11-07 | ||
| 2017-06-30 | $7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $18.20M 10-Q · filed 2017-08-08 | $25.70M derived: sum of 3 quarters · filed 2017-08-08 | |||
| 2017-03-31 | $10.50M 10-Q · filed 2017-05-08 | $18.00M derived: sum of 2 quarters · filed 2017-05-08 | ||||
| 2016-12-30 | $7.50M 10-QT · filed 2017-02-07 | |||||
| 2016-06-24 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-02 | $14.30M derived: sum of 2 quarters · filed 2016-08-02 | $23.60M 10-Q · filed 2016-08-02 | |||
| 2016-03-25 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-03 | $16.60M 10-Q · filed 2016-05-03 | ||||
| 2015-12-25 | $9.30M 10-Q · filed 2016-02-02 | |||||
| 2015-06-26 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $17.50M derived: sum of 2 quarters · filed 2015-08-04 | $32.30M 10-Q · filed 2015-08-04 | $49.50M derived: sum of 4 quarters · filed 2015-08-04 | ||
| 2015-03-27 | $11.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-05 | $26.10M 10-Q · filed 2015-05-05 | $43.30M derived: sum of 3 quarters · filed 2015-05-05 | $64.90M derived: sum of 4 quarters · filed 2015-05-05 | ||
| 2014-12-26 | $14.80M 10-Q · filed 2015-02-03 | $32.00M derived: sum of 2 quarters · filed 2015-04-03 | $53.60M derived: sum of 3 quarters · filed 2015-04-03 | $63.90M derived: sum of 4 quarters · filed 2015-04-03 | ||
| 2014-09-26 | $17.20M derived: 8-K 12 month − 10-Q 9 month · filed 2015-04-03 | $38.80M derived: sum of 2 quarters · filed 2015-04-03 | $49.10M derived: sum of 3 quarters · filed 2015-04-03 | $55.00M 8-K · filed 2015-04-03 | ||
| 2014-06-27 | $21.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-07 | $31.90M derived: sum of 2 quarters · filed 2014-08-07 | $37.80M 10-Q · filed 2014-08-07 | |||
| 2014-03-28 | $10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-08 | $16.20M 10-Q · filed 2014-05-08 | ||||
| 2013-12-27 | $5.90M 10-Q · filed 2014-02-07 | |||||
| 2013-09-27 | $15.10M 8-K · filed 2015-04-03 | |||||
| 2012-09-28 | $11.50M 8-K · filed 2015-04-03 | |||||
| 2011-09-30 | $3.50M 10-K · filed 2013-12-13 |